Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Clinical trial NCT02187991 · COMPLETED

Trial details

NCT number: NCT02187991
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Carcinoma Breast Tumors Malignant Neoplasm of Breast

Start date: 2015-02-12
Primary completion: 2024-04-11
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.